from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2110c/prcB

LFCtreatmentdescriptionclass of inhibitor

-1.020

Amikacinug/mL Amikacintranslation

-0.692

Cap5-10ug/mL Capreomycintranslation

-1.252

Rox10-50 ug/mL Roxithromycintranslation

-0.379

SM2-5 ug/mL Streptomycintranslation

-0.773

Tet5-10 ug/mL Tetracyclinetranslation

0.097

Rif0.2-5ug/mL Rifampicintranscription

-0.951

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.997

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.785

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.015

CPZ10-50 ug/mL Chlorpromazinerespiration

1.066

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.619

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.005

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.168

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.305

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.405

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.271

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.015

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.445

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.139

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.756

KCN5-20 ug/mL Potassium cyaniderespiration

-0.380

NaN30.2-2 mM Sodium aziderespiration

-1.812

Nigericin50 uM Nigericinrespiration

0.279

TRC10-150 ug/mL Triclosanrespiration

-0.218

TRZ10-25 ug/mL Thioridazinerespiration

0.265

Valinomycin0.5-10 uM Valinomycinrespiration

-1.273

ZnSO42 mM ZnSO4respiration

-0.848

menadione6-10 ug/mL Menadionerespiration

0.100

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.672

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.067

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.300

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.288

NRP_1Non-replicating persistence stage 1dosRassociated

0.228

Amp0.2mg/mL AmpicillincellWall

-0.287

Cephalexin20-100 ug/mL CephalexincellWall

-0.493

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.190

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.212

EMB10-20 ug/mL EthambutolcellWall

-0.512

Eta12-40 ug/mL EthionamidecellWall

-0.419

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.139

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-2.193

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.513

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.577

BZA0.12 mg/mL BenzamidearomaticAmides

0.636

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.188

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.723

H2O24 mM hydrogen peroxideDNAdamaging

-0.593

Levo10 ug/mL LevofloxacinDNAdamaging

0.705

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.196

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.149

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.257

UVUV-irradiationDNAdamaging

0.195

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.346

Antimycin12.5-50 ug/mL Antimycin A?

-1.744

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.507

PA_110-50 ug/mL Antitubercular compound PA-1?

0.136

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.444

PA8240.2-2 ug/mL PA-824?

1.332

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.667

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.486

Verapamil50 uM Verapamil?

-1.560

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.738

methoxatin10-20 ug/mL Methoxatin?